Results 141 to 150 of about 17,265 (194)

Comparative evaluation of TACE-RFA versus monotherapies on a background of systemic therapy for recurrent hepatocellular carcinoma: a propensity score-matched analysis. [PDF]

Front Oncol
Zhang W, Ye Z, Wang J, Ren X, Ying L, Wu Y, Wu Z, Xin C, Feng J.   +8 more
europepmc   +1 more source

Comparison between drug-eluting bead transarterial chemoembolization versus conventional TACE in elderly patients with colorectal cancer liver metastases: a cohort study. [PDF]

Front Oncol
Tian L, Hu B, Song M, Li Y, Yang F, Yang J.   +5 more
europepmc   +1 more source

Hepatocellular Carcinoma at a Center of Clinical Excellence in Colombia: A Real-World Cohort Study of Clinical Characteristics, Treatment Trajectories, and Survival. [PDF]

J Hepatocell Carcinoma
Torres-Vélez C, Sanabria-Jiménez A, Amaya-Nieto J, Ariza-De La Hoz M, Beltrán-Galvis O, Varón-Puerta A.   +5 more
europepmc   +1 more source

Dual-modality imaging with CEUS and MRI for early recurrence assessment in hepatocellular carcinoma following combined radiofrequency ablation and transarterial chemoembolization. [PDF]

Front Oncol
Jin S, Wang Q, Zhu L, Teng D, Sui G, Wang H.   +5 more
europepmc   +1 more source

Utility of intraoperative 3-dimensional C-arm cone-beam computed tomography for hepatic transarterial chemoembolization. [PDF]

Front Vet Sci
Jeon S, Lee G, Kim JK, Kim HC, Lee N, Chang D.   +5 more
europepmc   +1 more source

Umbilical vein recanalization identified on contrast-enhanced ultrasound in a patient with hepatocellular carcinoma during TACE assessment. [PDF]

Radiol Case Rep
KuonYeng-Escalante C, Liu JB, Xu J, Leung S, Lyshchik A, Eisenbrey JR.   +5 more
europepmc   +1 more source

The State of the Art on Management of Patients with Unresectable Liver Metastases from Colorectal Cancer. [PDF]

Biomedicines
Porto M, Luciano B, Simões J, Laureano M, Gil I, Pinheiro S, Caetano-Oliveira R, Martins R, Coelho M.   +8 more
europepmc   +1 more source

Therapeutic effectiveness of segmental arterioportal chemoembolization via hepatic artery for localized hepatocellular carcinoma

, 1993
openaire   +1 more source

Therapeutic effectiveness of segmental arterioportal chemoembolization via hepatic artery for localized hepatocellular carcinoma.

Therapeutic effectiveness of segmental arterioportal chemoembolization via hepatic artery for localized hepatocellular carcinoma.
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The therapeutic benefits of combined sorafenib and transarterial chemoembolization for advanced hepatocellular carcinoma

Journal of Digestive Diseases, 2020
ObjectiveSystemic therapy, such as sorafenib, has been used clinically to treat patients with advanced stage or Barcelona Clinic Liver Cancer staging system (BCLC) stage C hepatocellular carcinoma (HCC). The aim of the study was to evaluate the therapeutic benefit of combined sorafenib and transarterial chemoembolization (TACE) in this group of ...
Shou Wu Lee, Teng Yu Lee, Yen Chun Peng, Sheng Shun Yang, Hong Zen Yeh, Chi Sen Chang   +5 more
openaire   +2 more sources